Placebo
Placebo is a pharmaceutical drug with 40,617 clinical trials. Currently 4,644 active trials ongoing. Historical success rate of 87.4%.
Success Metrics
Based on 26,137 completed trials
Phase Distribution
Phase Distribution
8492
Early Stage
12598
Mid Stage
12807
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.6%
26137 of 31247 finished
16.4%
5110 ended early
4644
trials recruiting
40,617
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
A Single Ascending Dose Study of SYH2082 Injection in Healthy Participants
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Clinical Trials (40,617)
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
A Single Ascending Dose Study of SYH2082 Injection in Healthy Participants
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Vascular Impact of Omega-3 in Metabolic Syndrome
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)
Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
Treatment of Tinnitus With Migraine Medications
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies
Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Spironolactone in Alcohol Use Disorder (SAUD)
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 40,617